Search - tctmd.com

Displaying 961 - 980 of 3316

Sort: Relevancy | Date

Yet Another US Report Shows Stalled Progress Against CHD

News Daily News

Yet Another US Report Shows Stalled Progress Against CHD

January 19, 2022

Consider COVID-19 History in Pre-op CV Screening, Doctors Say

News Daily News

Consider COVID-19 History in Pre-op CV Screening, Doctors Say

January 14, 2022

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

News Daily News

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

January 14, 2022

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

News Daily News

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

Michael O'Riordan

January 12, 2022

‘Home Time’ Validated as TAVI Outcomes Performance Metric

News Daily News

‘Home Time’ Validated as TAVI Outcomes Performance Metric

January 11, 2022

Race, Income Remain Predictors of Acute MI Revascularization in Women

News Daily News

Race, Income Remain Predictors of Acute MI Revascularization in Women

Yael L. Maxwell

January 10, 2022

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

January 10, 2022

COVID-19: TCTMD’s Dispatch for January Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 2

January 10, 2022

Ad Hoc PCI Outcomes Similar No Matter Who Does the Diagnostic Cath

News Daily News

Ad Hoc PCI Outcomes Similar No Matter Who Does the Diagnostic Cath

January 04, 2022

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

News Daily News

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

December 29, 2021

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

December 28, 2021

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

December 27, 2021

Women Less Likely Than Men to Experience SCD During Sports

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

Studies Zero in on Delayed Conduction Problems After TAVI

News Daily News

Studies Zero in on Delayed Conduction Problems After TAVI

December 21, 2021

For Angina Patients, Language Barriers Can Complicate CVD Care

News Daily News

For Angina Patients, Language Barriers Can Complicate CVD Care

December 20, 2021

Smartphone App Hears Speech Changes Indicating Fluid Buildup in HF

News Daily News

Smartphone App Hears Speech Changes Indicating Fluid Buildup in HF

December 10, 2021

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

December 09, 2021

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

December 07, 2021

More Than One in 10 UK Cardiology Trainees Report Being Bullied

News Daily News

More Than One in 10 UK Cardiology Trainees Report Being Bullied

Yael L. Maxwell

December 07, 2021

COVID-19: TCTMD’s Dispatch for December Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for December Week 1

December 06, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.